Michael R. McGinnis - Concepedia

Author

Michael R. McGinnis

The University of Texas Medical Branch at Galveston ORCID

Also Known As

M McGinnis, M R McGinnis, M. R. MCGINNIS, M. R. McGINNIS, M. R. McGinnis, M.R. McGinnis, M.R. Mcginnis, MICHAEL R. MCGINNIS, MICHAEL R. McGINNIS, Michael McGinnis

212

Publications

7.2K

Citations

H-Index

113

Concepts

All Affiliations

The University of Texas Medical Branch at Galveston University of North Carolina at Chapel Hill Wadsworth Center

About

Michael R. McGinnis is an author at The University of Texas Medical Branch at Galveston specializing in medicine, microbiology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	74	4.4K
2	Natural Sciences	12	13	607
3	Engineering	9	9	542
4	Health Sciences	4	4	536
5	Education	1	1	18

Michael R. McGinnis

106

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Chromoblastomycosis and phaeohyphomycosis: New concepts, diagnosis, and mycology Michael R. McGinnis Journal of the American Academy of Dermatology Diagnostic MycologyHistopathologyPathologyNew ConceptsDermatology	1983	462
Early Clinical and Laboratory Diagnosis of Invasive Pulmonary, Extrapulmonary, and Disseminated Mucormycosis (Zygomycosis) Thomas J. Walsh, Maria N. Gamaletsou, Michael R. McGinnis, Clinical Infectious Diseases Invasive MucormycosisEarly DiagnosisTranslational MedicineDiagnostic MycologyMedicine	2012	370
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi Ana Espinel-Ingroff, Marilyn S. Bartlett, Raleigh A. Bowden, Journal of Clinical Microbiology Multicenter EvaluationClinical MycologyFusarium Spp.Drug ResistanceBioanalysis	1997	228
Tropical dermatology: Fungal tropical diseases Omar Lupi, Stephen K. Tyring, Michael R. McGinnis Journal of the American Academy of Dermatology Tropical DermatologyClinical MycologyDermatologyDermatopathologyMedicine	2005	204
Emerging agents of phaeohyphomycosis: pathogenic species of Bipolaris and Exserohilum Michael R. McGinnis, Michael G. Rinaldi, Richard E. Winn Journal of Clinical Microbiology BiologyDiagnostic MycologyPathogenic SpeciesEngineeringFungal Pathogen	1986	200
In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against <i>Blastomyces dermatitidis</i> , <i>Coccidioides immitis</i> , and <i>Histoplasma capsulatum</i> Renkai Li, Meral A. Cıblak, Nicole G. Nordoff, Antimicrobial Agents and Chemotherapy	2000	194
Differences in beta-glucan levels in culture supernatants of a variety of fungi Zekaver Odabaşı, Victor L. Paetznick, José C. Rodríguez‐Rey, Medical Mycology Beta-glucan LevelsFungal Cell BiologyGlycobiologyImmunologyPathology	2006	142
<i>Lacazia loboi</i> gen. nov., comb. nov., the Etiologic Agent of Lobomycosis Paulo R. Taborda, Valeria A. Taborda, Michael R. McGinnis Journal of Clinical Microbiology Parasitic DiseaseParasitic ProtozoaMedicinePathogenesisPathology	1999	141
In vitro evaluation of voriconazole against some clinically important fungi Michael R. McGinnis, L Pasarell, Deanna A. Sutton, Antimicrobial Agents and Chemotherapy MycologyFungal DiversityAntifungal AgentHealth SciencesMedicine	1997	131
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine Michael A. Pfaller, Martha J. Bale, Barry J. Buschelman, Journal of Clinical Microbiology Qc TestingMacrodilution TestingAntimicrobial ChemotherapyDrug ResistanceBioanalysis	1995	129

Page 1